Abstract
Peripartum cardiomyopathy (PPCM) refers to irreversible cardiomyocyte damage that occurs during the last month of pregnancy, or within 5 months after giving birth. It is characterized by systolic heart failure. This life-threatening condition is relatively uncommon, but the incidence has been climbing up. Because of its high mortality, it is crucial for physicians to have high suspicious for the disease. Studies have been done to search into specific lab test and treatment for PPCM. Therapies like anti-viral, anti-inflammatory and immunosuppression regimen have been explored. New regimen like exosomes has also been explored and revealed promising effects.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Demakis JG, Rahimtoola SH, Sutton GC, Meadows WR, Szanto PB, Tobin JR, Gunnar RM (1971) Natural course of peripartum cardiomyopathy. Circulation 44(6):1053–1061
Hibbard JU, Lindheimer M, Lang RM (1999) A modified definition for peripartum cardiomyopathy and prognosis based on echocardiography. Obstet Gynecol 94(2):311–316
Deneux-Tharaux C, Berg C, Bouvier-Colle MH, Gissler M, Harper M, Nannini A, Alexander S, Wildman K, Breart G, Buekens P (2005) Underreporting of pregnancy-related mortality in the United States and Europe. Obstet Gynecol 106(4):684–692
Brar SS, Khan SS, Sandhu GK, Jorgensen MB, Parikh N, Hsu JW, Shen AY (2007) Incidence, mortality, and racial differences in peripartum cardiomyopathy. Am J Cardiol 100(2):302–304
Desai D, Moodley J, Naidoo D (1995) Peripartum cardiomyopathy: experiences at King Edward VIII Hospital, Durban, South Africa and a review of the literature. Trop Dr 25(3):118–123
Elkayam U (2011) Clinical characteristics of peripartum cardiomyopathy in the United States: diagnosis, prognosis, and management. J Am Coll Cardiol 58(7):659–670
Ferriere M, Sacrez A, Bouhour JB, Cassagnes J, Geslin P, Dubourg O, Komajda M, Degeorges M (1990) Cardiomyopathy in the peripartum period: current aspects. A multicenter study. 11 cases. Arch Mal Coeur Vaiss 83(10):1563–1569
Gentry MB, Dias JK, Luis A, Patel R, Thornton J, Reed GL (2010) African-American women have a higher risk for developing peripartum cardiomyopathy. J am Coll Cardiol 55(7):654–659
Sliwa K, Skudicky D, Candy G, Bergemann A, Hopley M, Sareli P (2002) The addition of pentoxifylline to conventional therapy improves outcome in patients with peripartum cardiomyopathy. Eur J Heart Fail 4(3):305–309
Pearson GD, Veille JC, Rahimtoola S, Hsia J, Oakley CM, Hosenpud JD, Ansari A, Baughman KL (2000) Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. J Am Med Assoc 283(9):1183–1188
Sliwa K, Skudicky D, Bergemann A, Candy G, Puren A, Sareli P (2000) Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1. J Am Coll Cardiol 35(3):701–705
Sliwa K, Forster O, Libhaber E, Fett JD, Sundstrom JB, Hilfiker-Kleiner D, Ansari AA (2006) Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur Heart J 27(4):441–446
Chapa JB, Heiberger HB, Weinert L, Decara J, Lang RM, Hibbard JU (2005) Prognostic value of echocardiography in peripartum cardiomyopathy. Obstet Gynecol 105(6):1303–1308
Ntusi NB, Mayosi BM (2009) Aetiology and risk factors of peripartum cardiomyopathy: a systematic review. Int J Cardiol 131(2):168–179
Sanderson JE, Olsen EG, Gatei D (1986) Peripartum heart disease: an endomyocardial biopsy study. Br Heart J 56(3):285–291
Sliwa K, Forster O, Tibazarwa K, Libhaber E, Becker A, Yip A, Hilfiker-Kleiner D (2011) Long-term outcome of peripartum cardiomyopathy in a population with high seropositivity for human immunodeficiency virus. Int J Cardiol 147(2):202–208
Lyden DC, Huber SA (1984) Aggravation of coxsackievirus, group B, type 3-induced myocarditis and increase in cellular immunity to myocyte antigens in pregnant Balb/c mice and animals treated with progesterone. Cell Immunol 87(2):462–472
Ansari AA, Fett JD, Carraway RE, Mayne AE, Onlamoon N, Sundstrom JB (2002) Autoimmune mechanisms as the basis for human peripartum cardiomyopathy. Clin Rev Allergy Immunol 23(3):301–324
Hayakawa Y, Chandra M, Miao W, Shirani J, Brown JH, Dorn GW II, Armstrong RC, Kitsis RN (2003) Inhibition of cardiac myocyte apoptosis improves cardiac function and abolishes mortality in the peripartum cardiomyopathy of Galpha(q) transgenic mice. Circulation 108(24):3036–3041
Selle T, Renger I, Labidi S, Bultmann I, Hilfiker-Kleiner D (2009) Reviewing peripartum cardiomyopathy: current state of knowledge. Futur Cardiol 5(2):175–189
Bültmann BD, Klingel K, Näbauer M, Wallwiener D, Kandolf R (2005) High prevalence of viral genomes and inflammation in peripartum cardiomyopathy. Am J Obstet Gynecol 193(2):363–365
Kuhl U, Pauschinger M, Seeberg B, Lassner D, Noutsias M, Poller W, Schultheiss HP (2005) Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 112(13):1965–1970
Hilfiker-Kleiner D, Kaminski K, Podewski E, Bonda T, Schaefer A, Sliwa K, Forster O, Quint A, Landmesser U, Doerries C, Luchtefeld M, Poli V, Schneider MD, Balligand JL, Desjardins F, Ansari A, Struman I, Nguyen NQ, Zschemisch NH, Klein G, Heusch G, Schulz R, Hilfiker A, Drexler H (2007) A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 128(3):589–600
Patten IS, Rana S, Shahul S, Rowe GC, Jang C, Liu L, Hacker MR, Rhee JS, Mitchell J, Mahmood F, Hess P, Farrell C, Koulisis N, Khankin EV, Burke SD, Tudorache I, Bauersachs J, del Monte F, Hilfiker-Kleiner D, Karumanchi SA, Arany Z (2012) Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature 485(7398):333–338
Fett JD, Carraway RD, Dowell DL, King ME, Pierre R (2002) Peripartum cardiomyopathy in the Hospital Albert Schweitzer District of Haiti. Am J Obstet Gynecol 186(5):1005–1010
Keyser EA, Reed BG, Gonzalez-Brown V, Fausett B, Staat BC, Leath CA (2012) Peripartum cardiomyopathy and acute fatty liver of pregnancy: one patient with two zebras. Mil Med 177(4):470–473
Shah T, Ather S, Bavishi C, Bambhroliya A, Ma T, Bozkurt B (2013) Peripartum cardiomyopathy: a contemporary review. Methodist Debakey Cardiovasc J 9(1):38–43
Diao M, Diop IB, Kane A, Camara S, Kane A, Sarr M, Ba SA, Diouf SM (2004) Electrocardiographic recording of long duration (Holter) of 24 hours during idiopathic cardiomyopathy of the peripartum. Arch Mal Coeur Vaiss 97(1):25–30
Meyer GP, Labidi S, Podewski E, Sliwa K, Drexler H, Hilfiker-Kleiner D (2010) Bromocriptine treatment associated with recovery from peripartum cardiomyopathy in siblings: two case reports. J Med Case Rep 4(1):80–84
Helms AK, Kittner SJ (2005) Pregnancy and stroke. CNS Spectr 10(7):580–587
Mayosi BM (2007) Contemporary trends in the epidemiology and management of cardiomyopathy and pericarditis in sub-Saharan Africa. Heart 93(10):1176–1183
Napporn A, Kane A, Damorou J, Dia A, Diop I, Sarr M, Ba S, Diouf S (2000) Intraventricular thrombosis complicating peri-partum idiopathic myocardiopathy. Annales de Cardiologie et D’angeiologie 49(5):309–314
Bhakta P, Biswas BK, Banerjee B (2007) Peripartum cardiomyopathy: review of the literature. Yonsei Med J 48(5):731–747
Forster O, Hilfiker-Kleiner D, Ansari AA, Sundstrom JB, Libhaber E, Tshani W, Becker A, Yip A, Klein G, Sliwa K (2008) Reversal of IFN-gamma, oxLDL and prolactin serum levels correlate with clinical improvement in patients with peripartum cardiomyopathy. Eur J Heart Fail 10(9):861–868
Halkein J, Tabruyn SP, Ricke-Hoch M, Haghikia A, Nguyen NQ, Scherr M, Castermans K, Malvaux L, Lambert V, Thiry M, Sliwa K, Noel A, Martial JA, Hilfiker-Kleiner D, Struman I (2013) MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy. J Clin Investig 123(5):2143–2154
Hu CL, Li YB, Zou YG, Zhang JM, Chen JB, Liu J, Tang YH, Tang QZ, Huang CX (2007) Troponin T measurement can predict persistent left ventricular dysfunction in peripartum cardiomyopathy. Heart 93(4):488–490
Holzmann M, Nicko A, Kuhl U, Noutsias M, Poller W, Hoffmann W, Morguet A, Witzenbichler B, Tschope C, Schultheiss HP, Pauschinger M (2008) Complication rate of right ventricular endomyocardial biopsy via the femoral approach: a retrospective and prospective study analyzing 3048 diagnostic procedures over an 11-year period. Circulation 118(17):1722–1728
Bhattacharyya A, Basra SS, Sen P, Kar B (2012) Peripartum cardiomyopathy: a review. Tex Heart Inst J 39(1):8–16
Amos AM, Jaber WA, Russell SD (2006) Improved outcomes in peripartum cardiomyopathy with contemporary. Am Heart J 152(3):509–513
Witlin AG, Mabie WC, Sibai BM (1997) Peripartum cardiomyopathy: an ominous diagnosis. Am J Obstet Gynecol 176(1):182–188
Witlin AG, Mabie WC, Sibai BM (1997) Peripartum cardiomyopathy: a longitudinal echocardiographic study. Am J Obstet Gynecol 177(5):1129–1132
Murali S, Baldisseri MR (2005) Peripartum cardiomyopathy. Crit Care Med 33(10):340–346
Heart Failure Society of A, Lindenfeld J, Albert NM, Boehmer JP, Collins SP, Ezekowitz JA, Givertz MM, Katz SD, Klapholz M, Moser DK, Rogers JG, Starling RC, Stevenson WG, Tang WH, Teerlink JR, Walsh MN (2010) HFSA 2010 comprehensive heart failure practice guideline. J Card Fail 16(6):1–194
Adams KF Jr, Patterson JH, Gattis WA, O’Connor CM, Lee CR, Schwartz TA, Gheorghiade M (2005) Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: a retrospective analysis. J Am Coll Cardiol 46(3):497–504
Briggs GG, Ambrose PJ, Nageotte MP, Padilla G (2008) High-dose carisoprodol during pregnancy and lactation. Ann Pharmacother 42(6):898–901
Shotan A, Widerhorn J, Hurst A, Elkayam U (1994) Risks of angiotensin-converting enzyme inhibition during pregnancy: experimental and clinical evidence, potential mechanisms, and recommendations for use. Am J Med 96(5):451–456
Hurst A, Hoffman K, Frishman W, Elkayam U (1998) The use of beta adrenergic blocking agents in pregnancy and lactation. Wiley Liss 3(3):357–372
American Academy of Pediatrics Committee on D (2001) Transfer of drugs and other chemicals into human milk. Pediatrics 108(3):776–789
Shimamoto T, Marui A, Oda M, Tomita S, Nakajima H, Takeuchi T, Komeda M (2008) A case of peripartum cardiomyopathy with recurrent left ventricular apical thrombus. Circ J 72(5):853–854
Briggs GG, Freeman RK, Yaffe SJ (2012) Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. Lippincott Williams & Wilkins 10:1–1600
Turkalj I, Braun P, Krupp P (1982) Surveillance of bromocriptine in pregnancy. J Am Med Assoc 247(11):1589–1591
Barile L, Moccetti T, Marban E, Vassalli G (2016) Roles of exosomes in cardioprotection. Eur Heart J 7(21):304–312
Hajivalili M, Pourgholi F, Majidi J, Aghebati-Maleki L, Movassaghpour AA, Samadi Kafil H, Mirshafiey A, Yousefi M (2016) G2013 modulates TLR4 signaling pathway in IRAK-1 and TARF-6 dependent and miR-146a independent manner. Cell Mol Biol 62(4):1–5
Lorello G, Cubillos J, McDonald M, Balki M (2014) Peripartum cardiomyopathy: postpartum decompensation and use of non-invasive cardiac output monitoring. Int J Obstet Anesth 23(1):66–70
Rose EA, Moskowitz AJ, Packer M, Sollano JA, Williams DL, Tierney AR, Heitjan DF, Meier P, Ascheim DD, Levitan RG, Weinberg AD, Stevenson LW, Shapiro PA, Lazar RM, Watson JT, Goldstein DJ, Gelijns AC (1999) The rematch trial: rationale, design, and end points. Randomized evaluation of mechanical assistance for the treatment of congestive heart failure. Ann Thorac Surg 67(3):723–730
Jessup M, Brozena S (2003) Heart failure. N Engl J Med 348(20):2007–2018
Duran N, Gunes H, Duran I, Biteker M, Ozkan M (2008) Predictors of prognosis in patients with peripartum cardiomyopathy. Int J Obstet Gynaecol 101(2):137–140
Modi KA, Illum S, Jariatul K, Caldito G, Reddy PC (2009) Poor outcome of indigent patients with peripartum cardiomyopathy in the United States. Am J Obstet Gynecol 201(2):171–175
Biteker M (2012) Peripartum cardiomyopathy in Turkey. Int J Cardiol 158(3):60–61
Blauwet LA, Sliwa K (2011) Peripartum cardiomyopathy. Obstet Med 4(2):44–52
Gao M, Wang X, Zhang X, Ha T, Ma H, Liu L, Kalbfleisch JH, Gao X, Kao RL, Williams DL, Li C (2015) Attenuation of cardiac dysfunction in polymicrobial sepsis by microRNA-146a is mediated via targeting of IRAK1 and TRAF6 expression. J Immunol 195(2):672–682
Acknowledgements
This work was supported by the grants from National Natural Science Foundation of China (81370280 and 81570332), the grant from Yangpu Commission of Science and Technology Commission, and Yangpu Commission of Health and Family Planning (YP15M07), and the “Chenguang Program” supported by Yangpu Hospital, Tongji University School of Medicine (Ye1201409).
Competing Financial Interests The authors declare no competing financial interests.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Gu, H., Dai, Q., Liu, Z., Wang, H., Yao, J., Zhou, L. (2017). Peripartum Cardiomyopathy: Do Exosomes Play a Role?. In: Xiao, J., Cretoiu, S. (eds) Exosomes in Cardiovascular Diseases. Advances in Experimental Medicine and Biology, vol 998. Springer, Singapore. https://doi.org/10.1007/978-981-10-4397-0_9
Download citation
DOI: https://doi.org/10.1007/978-981-10-4397-0_9
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-4396-3
Online ISBN: 978-981-10-4397-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)